With a focus on innovation to support a healthier Australia and avoid future crises, life sciences continues to be an increasing focus and a critical development and investment area in the Australian economy. Funding, manufacturing and supply chain challenges remain a key concern to secure access to essential medicines and devices. Domestic and overseas stakeholders, however, are showing great interest in the Australian market.

There is opportunity for Australia's strong medical research base to be leveraged to improve product commercialisation. Working with healthcare industry participants, the life sciences sector can plays a critical role in a broader health ecosystem that embraces transformation and growth. We are helping the life sciences industry address those challenges to deliver innovative and accessible healthcare solutions to the market – both in Australia, and globally.

MEET AN EXPERT

Knowledge and expertise

Our depth of life sciences experience covers all aspects of advising on strategic M&A, capital raisings and IPOs, foreign investment, corporate governance, commercial transactions, commercialisation strategies, regulatory issues, intellectual property, patent and other litigation, competition law, employment issues, tax (including R&D tax concession, transfer pricing and ATO audits), insurance and management of claims arising from adverse outcomes, regulation of pharmaceuticals and medical devices including Therapeutic Goods Act requirements, compliance with industry standards and codes (including MA and MTAA), and reimbursement issues relating to the Pharmaceutical Benefits Scheme.

Lead contact